India Pharma Outlook Team | Friday, 07 July 2023
Alkem Labs has announced its entry into the field of ophthalmology with the release of a comprehensive portfolio of low-cost, high-quality eye care products. This strategic expansion demonstrates Alkem's dedication to innovation and meeting the diverse needs of patients suffering from various eye conditions. The company introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launch by providing ophthalmologists with innovative, quality, and affordable solutions for managing and treating eye diseases.
Furthermore, it is enhancing patients' knowledge and awareness with vital knowledge in a user-friendly and inclusive manner via a dedicated patient education website. Each sales package includes a scannable QR code that connects to a dedicated patient education website that provides interactive multilingual patient education in a user-friendly and inclusive manner. The nationwide launch of Alkem's ophthalmology segment ensures that patients throughout India have access to high-quality eye care formulations at a reasonable cost. These services are intended to raise the standard of eye care and improve patients' overall well-being.
Commenting on the new segment launch, Sandeep Singh, managing director, Alkem Laboratories said, "We are delighted to begin this new chapter in the company’s journey by entering the field of ophthalmology. In this new segment, we are aspiring to make it big with the introduction of new, innovative, and futuristic formulations.